Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Serum C-reactive protein, fibrinogen and D-dimer in patients with progressive cerebral infarction.

Zang RS, Zhang H, Xu Y, Zhang SM, Liu X, Wang J, Gao YZ, Shu M, Mei B, Li HG.

Transl Neurosci. 2016 Aug 22;7(1):84-88. doi: 10.1515/tnsci-2016-0013. eCollection 2016.

2.

Association of inflammatory markers and poor outcome in diabetic patients presenting with ST segment elevation myocardial infarction.

Belenkova Y, Karetnikova V, Diachenko A, Gruzdeva O, Blagoveshchenskaya O, Molodtsova T, Uchasova E, Barbarash O.

J Inflamm Res. 2015 May 20;8:107-16. doi: 10.2147/JIR.S76304. eCollection 2015.

3.

A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups.

Weng LC, Tang W, Rich SS, Smith NL, Redline S, O'Donnell CJ, Basu S, Reiner AP, Delaney JA, Tracy RP, Palmer CD, Young T, Yang Q, Folsom AR, Cushman M.

Thromb Res. 2014 Aug;134(2):462-7. doi: 10.1016/j.thromres.2014.05.018. Epub 2014 May 20.

4.

The association between blood coagulation activity and lung function: a population-based study.

Fogarty AW, Lewis SA, McKeever TM, Lowe GD, Clark L, Britton J.

PLoS One. 2010 Nov 16;5(11):e15014. doi: 10.1371/journal.pone.0015014.

5.

Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.

Palella FJ Jr, Gange SJ, Benning L, Jacobson L, Kaplan RC, Landay AL, Tracy RP, Elion R.

AIDS. 2010 Jul 17;24(11):1657-65. doi: 10.1097/QAD.0b013e3283389dfa.

6.

Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study.

Kim CX, Bailey KR, Klee GG, Ellington AA, Liu G, Mosley TH Jr, Rehman H, Kullo IJ.

PLoS One. 2010 Feb 5;5(2):e9065. doi: 10.1371/journal.pone.0009065.

7.

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.

Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, Erdmann J, Braund P, Engert JC, Bennett D, Coin L, Ashby D, Tzoulaki I, Brown IJ, Mt-Isa S, McCarthy MI, Peltonen L, Freimer NB, Farrall M, Ruokonen A, Hamsten A, Lim N, Froguel P, Waterworth DM, Vollenweider P, Waeber G, Jarvelin MR, Mooser V, Scott J, Hall AS, Schunkert H, Anand SS, Collins R, Samani NJ, Watkins H, Kooner JS.

JAMA. 2009 Jul 1;302(1):37-48. doi: 10.1001/jama.2009.954.

8.

The use of high-sensitivity assays for C-reactive protein in clinical practice.

Musunuru K, Kral BG, Blumenthal RS, Fuster V, Campbell CY, Gluckman TJ, Lange RA, Topol EJ, Willerson JT, Desai MY, Davidson MH, Mora S.

Nat Clin Pract Cardiovasc Med. 2008 Oct;5(10):621-35. doi: 10.1038/ncpcardio1322. Epub 2008 Aug 19. Review.

9.

Serum concentration of C-reactive protein is not a good marker of bronchial hyperresponsiveness.

Panaszek B, Liebhart E, Liebhart J, Pawłowicz R, Fal AM.

Arch Immunol Ther Exp (Warsz). 2007 Sep-Oct;55(5):341-5.

Supplemental Content

Support Center